A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567.
Clinical trial NCT02760316 · COMPLETED
Trial details
- NCT number
- NCT02760316
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-02
- Primary completion
- 2017-09-11
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.